| 1 |
34905223 | Inhibitors of ectonucleotidases have paradoxical effects on synaptic transmission in the mouse cortex. | 2022 Feb |
1 |
| 2 |
32935303 | Effect of estradiol on enzymes of vascular extracellular nucleotide metabolism. | 2021 Mar |
2 |
| 3 |
33683190 | CD39/CD73/A2a Adenosine Metabolic Pathway: Targets for Moxibustion in Treating DSS-Induced Ulcerative Colitis. | 2021 |
1 |
| 4 |
32999463 | Negative feedback control of neuronal activity by microglia. | 2020 Oct |
2 |
| 5 |
30718407 | IL-27 confers a protumorigenic activity of regulatory T cells via CD39. | 2019 Feb 19 |
1 |
| 6 |
31022908 | Biotin Is Required for the Zinc Homeostasis in the Skin. | 2019 Apr 24 |
2 |
| 7 |
29332180 | CD39-adenosinergic axis in renal pathophysiology and therapeutics. | 2018 Jun |
1 |
| 8 |
29725032 | Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells. | 2018 Sep |
1 |
| 9 |
27208163 | Purinergic dysregulation in pulmonary hypertension. | 2016 Jul 1 |
2 |
| 10 |
27417582 | Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice. | 2016 Sep |
1 |
| 11 |
22540145 | 5'-Ectonucleotidase-knockout mice lack non-REM sleep responses to sleep deprivation. | 2012 Jun |
6 |
| 12 |
22613024 | Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice. | 2012 Jul |
2 |
| 13 |
22622462 | Defective renal water handling in transgenic mice over-expressing human CD39/NTPDase1. | 2012 Aug 1 |
1 |
| 14 |
21390184 | Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. | 2011 Mar |
2 |
| 15 |
21656186 | Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia. | 2011 Dec |
1 |
| 16 |
21807070 | Distribution of ecto-nucleotidases in mouse sensory circuits suggests roles for nucleoside triphosphate diphosphohydrolase-3 in nociception and mechanoreception. | 2011 Oct 13 |
2 |
| 17 |
21939667 | Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury. | 2011 Dec |
3 |
| 18 |
20146261 | Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice. | 2010 May |
1 |
| 19 |
20546740 | CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. | 2010 Sep |
2 |
| 20 |
21063242 | Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury. | 2010 Dec 27 |
1 |
| 21 |
19333785 | Ectonucleotidases in the kidney. | 2009 Dec |
1 |
| 22 |
17473221 | The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. | 2007 Sep |
1 |
| 23 |
17909107 | CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. | 2007 Oct 16 |
1 |
| 24 |
16616242 | Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties. | 2006 Apr |
4 |
| 25 |
15632415 | Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling. | 2005 May |
1 |
| 26 |
14983235 | Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. | 2004 Mar |
2 |
| 27 |
15146241 | Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. | 2004 May |
1 |
| 28 |
12649347 | Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. | 2003 Apr |
1 |
| 29 |
11929769 | Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. | 2002 Apr 15 |
1 |
| 30 |
11465076 | New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. | 2000 Nov |
1 |
| 31 |
10656876 | Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. | 1999 Nov |
1 |